Table 3.
GCLC GAG TNR genotypes in the Swiss sample
| Genotypes | Controls |
Patients |
OR | 95% CI | P value | ||
|---|---|---|---|---|---|---|---|
| N | % | N | % | ||||
| 7/7 | 24 | 50.0 | 20 | 30.3 | 0.44 | 0.20–0.94 | 0.033 |
| 7/8 | 2 | 4.2 | 13 | 19.7 | 5.64 | 1.21–26.32 | 0.015 |
| 7/9 | 21 | 43.7 | 22 | 33.3 | 0.64 | 0.30–1.38 | 0.257 |
| 8/8 | 0 | — | 2 | 3.0 | 0.57 | 0.48–0.67 | 0.333 |
| 8/9 | 1 | 2.1 | 5 | 7.6 | 3.9 | 0.43–34.1 | 0.195 |
| 9/9 | 0 | — | 4 | 6.1 | 0.56 | 0.48–0.66 | 0.108 |
| Controls vs. patients: (24, 2, 21, 0, 1, and 0 vs. 20, 13, 22, 2, 5, and 4)* | 0.012 | ||||||
N, number of genotypes in a group; %, percentage of genotypes in a group. Data are given together with OR and 95% confidence interval (CI). P values were calculated using χ 2 test (two-tailed), or Fisher exact test (two-tailed) if cells had an expected count of <5.
*The frequency of genotypes between patients and controls was compared using Fisher exact test (two-tailed) with a 2 × 6 contingency table (controls and patients × genotypes 7/7, 7/8, 7/9, 8/8, 8/9, and 9/9).